BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28934904)

  • 1. Clonal deletion of T cell repertoires with specific T cell receptor Vβ chains by two endogenous superantigens in NC/Nga mice.
    Ohkusu-Tsukada K; Tsukada T; Takahashi K
    Biosci Biotechnol Biochem; 2017 Nov; 81(11):2160-2163. PubMed ID: 28934904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Viral superantigens].
    Us D
    Mikrobiyol Bul; 2016 Jul; 50(3):491-504. PubMed ID: 27525406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pairing of Vbeta6 with certain Valpha2 family members prevents T cell deletion by Mtv-7 superantigen.
    Aude-Garcia C; Attinger A; Housset D; MacDonald HR; Acha-Orbea H; Marche PN; Jouvin-Marche E
    Mol Immunol; 2000 Nov; 37(16):1005-12. PubMed ID: 11395139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
    J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
    Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M
    J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM; Wallace VA; Timms E; Mak TW
    Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alleviation of renal disease and lymphadenopathy in MRL-Fasp(lrcg)/Fas(lprcg) (MR-lpr(cg)) mice neonatally infected with mouse mammary tumor virus encoding superantigen strongly reactive with TCR Vbeta8.2 element.
    Matsuzawa A; Yasuda T; Zhang Y; Nagase H; Yoshimoto T; Kimura M; Tsubura A
    Viral Immunol; 2000; 13(3):297-311. PubMed ID: 11016595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
    Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
    J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigens of mouse mammary tumor virus.
    Acha-Orbea H; MacDonald HR
    Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen.
    Maillard I; Xenarios I; Diggelmann H; Orbea HA
    Eur J Immunol; 1998 Oct; 28(10):3075-85. PubMed ID: 9808176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic deletion, escape from deletion and activation of mouse mammary tumor virus superantigen-reactive T cells in C57BL/10 mice.
    Dyson PJ; Elliott JI
    Eur J Immunol; 1999 May; 29(5):1456-66. PubMed ID: 10359099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse mammary tumor virus superantigens and murine autoimmune gastritis.
    Claeys D; Karapetian O; Saraga E; Schreyer M; Louis J; Acha-Orbea H; Blum AL; Kraehenbuhl JP
    Gastroenterology; 1994 Oct; 107(4):924-33. PubMed ID: 7926482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lineage-specific control of superantigen-induced cell death by the protein tyrosine kinase p56(lck).
    Penninger JM; Wallace VA; Molina T; Mak TW
    J Immunol; 1996 Dec; 157(12):5359-66. PubMed ID: 8955183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of an Mls-1-specific monoclonal antibody.
    Mohan N; Mottershead D; Subramanyam M; Beutner U; Huber BT
    J Exp Med; 1993 Feb; 177(2):351-8. PubMed ID: 8381154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabies superantigen as a Vbeta T-dependent adjuvant.
    Astoul E; Lafage M; Lafon M
    J Exp Med; 1996 Apr; 183(4):1623-31. PubMed ID: 8666920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.